Related Experiment Video
Updated: May 9, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Palliative sedation with propofol for refractory agitation.
Kelvin Lou1, Brian Li2, Shikha Minhas2
1The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada klou@alumni.ubc.ca.
Palliative sedation effectively manages end-of-life symptoms. Propofol offers a valuable option for refractory cases when standard treatments fail, improving patient comfort.
Area of Science:
- Palliative Care
- Oncology
- Pharmacology
Background:
- Palliative sedation is crucial for managing refractory symptoms in end-of-life care.
- Limited research exists on managing symptoms resistant to standard sedation protocols.
- Effective symptom management is essential for patient comfort and quality of life.
Related Concept Videos
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

